Celldex Therapeutics
CLDX
#3753
Rank
S$3.56 B
Marketcap
$53.72
Share price
0.19%
Change (1 day)
49.65%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -$3.27

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.13. In 2022 the company made an earnings per share (EPS) of -$3.11 a decrease over its 2021 EPS that were of -$2.14.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.275.12%
2022-$3.1145.73%
2021-$2.14-23.36%
2020-$2.79-41.05%
2019-$4.73-76.95%
2018-$20.5145.03%
2017-$14.15-42.54%
2016-$24.62-3.82%
2015-$25.59-0.76%
2014-$25.7929.41%
2013-$19.93-0%
2012-$19.93-9.73%
2011-$22.081312.5%
2010-$1.56-95.79%
2009-$37.09-49.64%
2008-$73.66-82.64%
2007-$424.37-44.98%
2006-$771.361270.83%
2005-$56.2733.33%
2004-$42.20-10%
2003-$46.89-16.67%
2002-$56.27-38.46%
2001-$91.44-4.88%
2000-$96.13-81.66%
1999-$524.01-87.2%
1998-$4,092206.39%
1997-$1,33613.02%
1996-$1,182

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.22 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.11-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-$15.73 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.43-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.42-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.56-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.74-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA